Business ❯ Corporate Governance ❯ Regulatory Compliance ❯ FDA Regulations

Product Safety

DexCom Investor Suits Intensify as Firms Set Competing Lead-Plaintiff Deadlines

Plaintiffs frame the dispute around unapproved sensor changes that allegedly degraded device accuracy.

DexCom Faces Wave of Securities Class Actions Over FDA-Faulted CGM Changes